Crossmark

Repositioning of experimentally validated anti-breast cancer peptides to target FAK-PAX complex to halt the breast cancer progression: a biomolecular simulation approach

Crossref DOI link: https://doi.org/10.1007/s11030-022-10438-0

Published Online: 2022-05-30

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khan, Abbas

Shan, Shengzhou

Toor, Tayyba Fatima

Suleman, Muhammad

Wang, Yanjing

Zhou, Jia

Wei, Dong-Qing
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82072175)

Ministry of Science and Technology of the People's Republic of China (61832019)
License Information

Text and Data Mining valid from 2022-05-30

Version of Record valid from 2022-05-30
More Information

Article History

Received: 20 November 2021

Accepted: 7 April 2022

First Online: 30 May 2022

Document is current

Any future updates will be listed below